Gilead HIV Drug Case Gets California Supreme Court Look
(Subscription required) The California Supreme Court will hear arguments in a case brought by more than 24,000 plaintiffs against the drugmaker. The claims depart from prior design defect arguments by alleging that the company’s delays in developing a new, safer HIV drug harmed them, according to a Wednesday docket filing.
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.